Liquid Copolymer Model for Drug Compatibility Testing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods lack a simple and reliable way to predict the compatibility and stability of biologically active substances with N-vinylpyrrolidone copolymers, especially when small amounts of the active ingredient are available, which is crucial for developing new drug products and ensuring homogeneity and release characteristics.
Innovation Solution
A liquid mixture of 1,3-bis(pyrrolidon-1-yl)butane with specific compounds simulates the dissolving properties of N-vinylpyrrolidone copolymers, allowing for the evaluation of compatibility by determining the phase behavior and solubility of biologically active substances, using a test system that includes 1,3-bis(pyrrolidon-1-yl)butane and compounds with structural similarity to the copolymer units.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If melt extrusion is used to produce solid dispersions, then homogeneous microdisperse phases can be achieved, but relatively large amounts of active ingredient are required
Solution Approach 1:
The patent creates a liquid model system that copies the dissolving behavior of N-vinylpyrrolidone copolymers. By using 1,3-bis(pyrrolidon-1-yl)butane combined with compounds having structural similarity to comonomer units, the test system reproduces the essential solvation characteristics without requiring actual copolymer production, enabling prediction of solid dispersion formation with minimal active ingredient
Solution Approach 2:
The liquid mixture acts as an intermediary between the active ingredient and the actual copolymer system. It provides a simplified medium that mediates the evaluation of compatibility and solubility, allowing predictions about solid dispersion formation without direct use of the copolymer in the test phase
2Quantity of substance
If small amounts of active ingredient are used, then resource efficiency is improved, but prediction of compatibility becomes uncertain
Solution Approach 1:
By creating a liquid model that copies the essential dissolving properties of the copolymer system, the patent enables reliable compatibility prediction with minimal active ingredient. The model system reproduces key solvation characteristics, allowing accurate predictions even when only small amounts of active ingredient are available for testing
3Stability of the object's composition
If compatibility testing is performed to ensure stability, then phase separation can be prevented, but additional time and resources are required
Solution Approach 1:
The patent employs a simple liquid test system using readily available compounds rather than complex copolymer systems. This disposable-like approach allows rapid screening of compatibility without the need for extensive long-term stability studies, reducing both time and resource requirements while maintaining predictive value
Solution Approach 2:
The liquid compatibility test serves as a preliminary screening tool that predicts potential phase separation issues before actual solid dispersion production. By performing this preliminary evaluation, the patent prevents wasted resources on incompatible formulations and identifies promising candidates for further development
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables prediction of compatibility and stability, ensuring the formation of homogeneous solid dispersions and preventing recrystallization, thus facilitating the development of stable drug products even with limited active ingredient availability.
Implementation Method 1
the dissolving properties of N-vinylpyrrolidone copolymers can be simulated by a liquid mixture of 1,3-bis(pyrrolidon-1-yl)butane with certain compounds which have structural similarity to the comonomer units present in the copolymer
Data Source
AI summary
A test solution agent, a test system and a method for evaluating the compatibility of biologically active substances with N-vinylpyrdolidone are disclosed.